The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you ...

Cardinal Health has updated its financial outlook for fiscal year 2026 non-GAAP diluted earnings per share (EPS) to at least ...

The healthcare services company says it expects to bring in over $50 billion in specialty revenue in fiscal 2026.

We recently compiled a list of the 10 Best Investments During A Recession. Cardinal Health, Inc. is one of the best ...

Cardinal Health has introduced ContinuCare Pathway, a pharmacy-to-supplier referral pathway program designed to help retail ...

Cardinal Health (CAH) ended the recent trading session at $208.26, demonstrating a +2.83% change from the preceding day's closing price. The stock outperformed the S&P 500, which registered a daily ...

The drug distributors continue to relentlessly climb higher. There’s nothing, you know, people hate the pharma middleman.

Drug distributor Cardinal Health raised its 2026 profit forecast on Tuesday, driven ​by robust demand for specialty medicines ...

Get the live share price of Cardinal Health Inc (CAH), including intraday charts, historical performance, key financials, and ...

Choose Columbus Business First as a preferred news source to see more of our reporting on Google.

Initiating Cardinal Health, Inc. with a Buy rating and $239 fair value, driven by specialty distribution growth and successful GMPD turnaround. Specialty segments in autoimmune, urology, and oncology ...

DUBLIN, Ohio, Oct. 30, 2025 /PRNewswire/ -- Cardinal Health today reported first quarter fiscal year 2026 revenues of $64 billion, an increase of 22% from the first quarter of fiscal year 2025. First ...